As explained in today’s edition of Smart Tech 50 Weekly Movers, we are selling Oracle (ORCL) and Intel (INTC) out of the STI Investments Portfolio now that they have closed beneath their stop prices and carry a Smart Tech Rating score less than the sector average. We are… Read More
Jim Pearce is the Chief Investment Strategist of Personal Finance, our flagship publication, and manages two trading services, PF Pro and Mayhem Trader. He began his career as a stockbroker in 1983 and over the years has managed client investment portfolios for major banks, brokerage firms, and investment advisors. Jim earned a BA from The College of William & Mary and the CFP designation from the College of Financial Planning.
Analyst Articles
As explained in today’s edition of Smart Tech 50 Weekly Movers, we are selling Oracle (ORCL) and Intel (INTC) out of the STI Investments Portfolio now that they have closed beneath their stop prices and carry a Smart Tech Rating score less than the sector average. We are… Read More
Okay, it looks like the long awaited correction is finally here. Like waiting for the first snow storm of the winter, usually the reality of its destruction is far greater than the excitement of its arrival. Regardless, the fact of the matter is it’s here, and now we all have… Read More
Okay, it looks like the long awaited correction is finally here. Like waiting for the first snow storm of the winter, usually the reality of its destruction is far greater than the excitement of its arrival. Regardless, the fact of the matter is it’s here, and now we all have… Read More
Is the stock market halfway to a correction, or poised for a rebound? Read More
As explained in today’s edition of Smart Tech Investor we are adding medical equipment manufacturer Greatbatch (GB) to our Medical Profits portfolio with a buy limit of $55, and New Relic (NEWR) to our Next Wave portfolio with a buy limit of $36.50. Read More
As explained in today’s edition of Smart Tech Investor we are adding medical equipment manufacturer Greatbatch (GB) to our Medical Profits portfolio with a buy limit of $55, and New Relic (NEWR) to our Next Wave portfolio with a buy limit of $36.50. Read More
- August 17, 2015
-
Download Issue
Last week’s currency devaluation by China threw the global financial markets for a loop, affecting the values of stocks, bonds, commodities and other currencies. As a result, many tech stocks came under the microscope, especially those such as Apple and Qualcomm that do a lot of business in Asia. If… Read More
Last week’s currency devaluation by China threw the global financial markets for a loop, affecting the values of stocks, bonds, commodities and other currencies. As a result, many tech stocks came under the microscope, especially those such as Apple and Qualcomm that do a lot of business in Asia. If… Read More
[From the 8/10/2015 edition of Smart Tech 50 Weekly Movers]We added Teradata (NYSE: TDC) to the Next Wave Portfolio in May of 2014, when it was trading at $40. Since then it has traded as high as $47, but over the past two quarters it has gradually… Read More